NSCLC NON-SMALL CELL LUNG CANCER

Clinical trials for NSCLC NON-SMALL CELL LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new NSCLC NON-SMALL CELL LUNG CANCER trials appear

Sign up with your email to follow new studies for NSCLC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 21 Not yet recruiting 8 Not yet finished but already full! 2 Completed 1

New combo therapy aims to boost lung cancer fight before and after surgery

Disease control Completed

This study tested if adding a newer immunotherapy drug (MEDI4736) to standard chemotherapy could better control a specific type of lung cancer (stage IIIA). The treatment was given both before surgery (to shrink the tumor) and after surgery (to prevent it from coming back). The g…

Matched conditions: NSCLC NON-SMALL CELL LUNG CANCER

Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

NSCLC NON-SMALL CELL LUNG CANCER

Get alerted when new NSCLC NON-SMALL CELL LUNG CANCER trials appear

New combo therapy aims to boost lung cancer fight before and after surgery